cysteine has been researched along with Action Myoclonus-Renal Failure Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farhan, SM; Hegele, RA; Murphy, LM; Prasad, AN; Robinson, JF; Rupar, CA; Siu, VM; Wang, J | 1 |
| Caldarelli, I; Catania, S; Cipollini, E; Dal Piaz, F; Dembic, M; Di Giaimo, R; Melli, M; Pulice, G; Riccio, M; Santi, S | 1 |
2 other study(ies) available for cysteine and Action Myoclonus-Renal Failure Syndrome
| Article | Year |
|---|---|
Linkage analysis and exome sequencing identify a novel mutation in KCTD7 in patients with progressive myoclonus epilepsy with ataxia.
Topics: Adolescent; Ataxia; Child, Preschool; Chromosome Mapping; Chromosomes, Human, Pair 7; Cysteine; Electroencephalography; Exome; Female; Genetic Linkage; Humans; Infant; Male; Mutation; Myoclonic Epilepsies, Progressive; Potassium Channels; Tyrosine | 2014 |
Cystatin B and its EPM1 mutants are polymeric and aggregate prone in vivo.
Topics: Animals; Cell Line; Chromatography, Gel; Cystatin B; Cystatins; Cysteine; Humans; Hydrogen-Ion Concentration; Mass Spectrometry; Microscopy, Electron; Mutant Proteins; Myoclonic Epilepsies, Progressive; Oxidants; Protein Structure, Quaternary; Rats; Recombinant Fusion Proteins; Reducing Agents; Time Factors; Transfection | 2008 |